Found 318 matching trials
Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT) PHASE2 The PUMP-IT study is designed to prove the feasibility of HAIP chemotherapy...
Show More Location
Antoni van Leeuwenhoek (NKI-AVL)
Learn More & Join Trial
mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line PHASE2 In second line with advanced or recurrent biliary tract cancer refractory t...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases PHASE2 Approximately 40% of colorectal cancer patients will develop colorectal liv...
Show More Location
Severance Hospital, Yonsei University Health System
Learn More & Join Trial
Phase I Trial of Combination of FOLFIRI and SOM 230 PHASE1 This is a single-arm, open-label, phase I study of combination therapy with...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma PHASE3 This Phase III, multicenter, randomized, open-label, controlled study is de...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial PHASE2 This is a multi-center, open-label, randomized, phase 2, two-arm clinical t...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of ABT-165 in Subjects With Solid Tumors PHASE1 This is a Phase 1/1b open-label study evaluating the safety, pharmacokineti...
Show More Location
HonorHealth Research Institute - Pima /ID# 105677
Learn More & Join Trial
FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer PHASE2 To observe and evaluate the efficacy and safety of FOLFOX/FOLFIRI± target-d...
Show More Location
Liaoning Cancer Hospital & Institute
Learn More & Join Trial
A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 PHASE1 This is an open-label Phase 1a/b dose-escalation study to assess the safety...
Show More Learn More & Join Trial
Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer PHASE2 The AMALTHEA (Aflibercept MAintenance after first-Line THErapy with FOLFIRI...
Show More Location
Agios Georgios Chania General Hospital
Learn More & Join Trial